| Name | Title | Contact Details |
|---|
Family Service League is a nationally accredited human services agency that has taken an active role in strengthening families and empowering the residents of Long Island for more than 90 years. We currently have over 50 programs in 21 locations, including 5 Family Centers, designed to help children, families in crisis, senior citizens, people who are homeless, unemployed, or mentally ill. Family Service League works to give them the resources they need in order to be self-reliant and productive members of our communities.
nTELAGENT, Inc is a Brentwood, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Apollo Light Systems is a Orem, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Neuralstem is a dual platform regenerative medicine company. The company`s technology enables the production of regionally specific, physiologically relevant neural stem cells for therapeutic use for the treatment of central nervous system (CNS) diseases and has enabled the discovery of a library of patented small molecule neurogenic compounds to treat psychological and cognitive disorders. Neuralstem`s small molecule drug discovery program screens human neural stem cell lines for compounds that may stimulate neurogenesis in the brain, possibly reversing pathologies associated with certain CNS conditions. The company`s lead compound, NSI-189, has completed FDA Phase Ia and Ib safety trials for the treatment of major depressive disorder (MDD). Neuralstem is expecting to launch a Phase II study for MDD in 2015. Neuralstem`s first stem cell therapy product, NSI-566, a spinal cord-derived neural stem cell line, is in ongoing clinical trials to treat amyotrophic lateral sclerosis (ALS, or Lou Gehrig`s disease), for which it has received orphan status designation by the FDA. Dosing in a phase IIa trial was completed in July, 2014. The next trial is anticipated to commence in 2015. In addition to ALS, the company is conducting an NSI-566 Phase I trial in chronic spinal cord injury, with NSI-566 clinical development also underway to treat ischemic
Triple Ring Technologies is a Newark, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.